PRKAA1 and leukemia: We identified a singular MLL-specific hyperactivated pathway that through AMPK phosphorylation leads to the activation of BCL-2, a well known anti-apoptotic regulator crucial for chemotherapy resistance already found to be over-expressed both at mRNA and protein levels in MLL-rearranged leukemias [18].